Trial Profile
An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pregnenolone (Primary)
- Indications Autistic disorder
- Focus Adverse reactions
- 03 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 according to ClinicalTrial.gov.
- 03 Jul 2013 New trial record